TRT on TikTok: separating protocol facts from bro-science

What did @trtsgtmaj2 actually say?

The creator switched TRT clinics primarily because their previous provider prescribed gonadorelin instead of HCG (human chorionic gonadotropin). They describe HCG as "the holy grail," claiming it keeps testicular size intact, preserves fertility, and "even increases sensitivity down there." They also say gonadorelin "doesn't work," full stop.

To be fair, they are not making up the debate. The HCG-versus-gonadorelin question is a real and active one in men's health medicine, and it is not fully settled. The creator is sharing a genuine patient preference, not fabricating a controversy. But "it doesn't work" is a much stronger claim than the evidence actually supports, and some of the HCG praise is oversimplified.

Does the science back this up?

HCG has a stronger and longer evidence base for preserving testicular function during TRT. Gonadorelin's case is more complicated, and the creator's blanket dismissal is not entirely wrong, but it goes too far.

HCG mimics luteinizing hormone (LH) directly at the Leydig cell receptor, stimulating intratesticular testosterone production. Studies including Coviello et al. (2005, Journal of Clinical Endocrinology and Metabolism) confirmed that low-dose HCG co-administered with exogenous testosterone maintained intratesticular testosterone concentrations. That matters for spermatogenesis, which exogenous testosterone alone suppresses.

Gonadorelin is a GnRH agonist administered via pulse dosing. The physiological problem is that continuous GnRH receptor stimulation causes downregulation. Pulsatile delivery is critical for it to work at all. Whether subcutaneous injections at typical telehealth doses replicate the natural pulsatile pattern well enough is legitimately questioned. There is limited published clinical data specifically on gonadorelin co-administration with TRT at the doses used in outpatient hormone clinics, which is a real gap. However, "doesn't work" and "limited efficacy data" are two different things.

What did they get wrong (or right)?

They got the core biology roughly right on HCG. They got too aggressive calling gonadorelin completely ineffective.

On HCG and fertility preservation, the science supports them. Wenker et al. (2015, Journal of Urology) found that HCG use during testosterone therapy helped maintain sperm production in men who wanted to father children. That lines up with what the creator is saying about staying fertile on TRT.

On testicular size, yes. HCG does help prevent the testicular atrophy that exogenous testosterone causes by suppressing the HPG axis. The "warehouse" metaphor is colorful but the underlying point is physiologically sound.

On "increases sensitivity," this is where things get murkier. Some men anecdotally report improved scrotal sensitivity or sexual sensation with HCG. Intratesticular testosterone and local hormonal signaling may play a role. But there is no robust randomized controlled trial data specifically attributing penile or scrotal sensitivity improvement to HCG co-administration. This claim is largely anecdote-based and should be treated as such.

On gonadorelin not working at all: this is an overstatement. The mechanistic concern about pulsatility is valid. But calling it categorically ineffective without citing any evidence is sloppy, even if the clinical skepticism is understandable.

What should you actually know?

If fertility preservation is your actual goal on TRT, HCG has substantially more supporting evidence than gonadorelin right now. That is a reasonable basis for a clinical preference.

However, HCG is not without tradeoffs. It can increase estradiol conversion more than gonadorelin due to its direct LH-receptor activity at the Leydig cell level, which means some men need closer estrogen monitoring. It also varies in availability depending on compounding regulations in your region, and compounded HCG is not equivalent to FDA-approved formulations, a distinction that matters clinically and legally.

Gonadorelin is not a sham. It is a legitimate GnRH analog with real pharmacology. The question is whether the subcutaneous dosing protocols used in telehealth practice reliably reproduce pulsatile GnRH signaling. That is an honest clinical uncertainty, not proof of failure. If you are on gonadorelin and your clinical markers look fine, do not panic based on a TikTok video.

Neither HCG nor gonadorelin should be added to your protocol without proper bloodwork and a prescribing clinician reviewing your specific situation. What works well for one patient may not be appropriate for another.